HOME ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE STORY OF OUR FIRM SEARCH

Thursday, August 28, 2008

Clinical Trials for Mesothelioma Patients: Immunotoxin Therapy Outcome Measures

Read about the outcome measures for a current clinical trial being conducted to study the effects of Immunotoxin Therapy for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, the study is currently being conducted only in Zurich, Switzerland.

Primary Outcome Measures:
• Maximum tolerated dose of SS1(dsFv)-PE38 immunotoxin [ Designated as safety issue: Yes ]
• Pharmacokinetics of SS1(dsFv)-PE38 immunotoxin [ Designated as safety issue: No ]
• Antitumor response [ Designated as safety issue: No ]

Secondary Outcome Measures:
• Measurement of antibody formation to drug and impact on pharmacokinetics [ Designated as safety issue: No ]

Recruitment Information:
Recruitment Status: Recruiting
Enrollment: 24
Estimated Start Date: June 2007
Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney


Mesothelioma & Asbestosis Mortalities Across the US: 1979-2001 (c/o EWG)

“We have seen first-hand how asbestos has wreaked havoc on Americans working in naval shipyards, automobile plants, and the construction industry. Most often this is through their employers’ conscious choice for profits over a worker's health.”

-- Joseph Patrick Williams, a trial attorney in the Asbestos Litigation department of Weitz & Luxenberg

CONTACT WEITZ & LUXENBERG FOR A FREE LEGAL EVALUATION OF YOUR CASE

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING
TABLE OF CONTENTS
Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


IN THIS SECTION
Immunotoxin therapy for mesothelioma patients
Objectives of Immunotoxin trial on mesothelioma
Study outline for Immunotoxin mesothelioma trial
Disease traits in Immunotoxin mesothelioma trial
Patient traits: Immunotoxin mesothelioma trial
Contact info for Immunotoxin mesothelioma program

RETURN BACK TO
Mesothelioma
Symptoms, Stages, Treatment of Mesothelioma
Treatment
Clinical trials on asbestos illness: mesothelioma
see also:

Study outline for Immunotoxin mesothelioma trial Study outline for program to treat mesothelioma with Immunotoxin
Study outline for identifying effects of Immunotoxin on mesothelioma

Disease traits in Immunotoxin mesothelioma trial Patient disease characteristics to treat mesothelioma with Immunotoxin
Study to identify effects of Immunotoxin on mesothelioma disease

Current Immunotoxin therapy: mesothelioma patients Current clinical trial of Immunotoxin therapy: mesothelioma patients
Immunotoxin may inhibit cancer cell growth in mesothelioma test

Name Phone Email
Do you have a legal question? Ask us!   strictly confidential
Your Question